ClosedPublished 5 Oct 2022
Pfizer Inc. /
GBT
Pfizer Inc. completes acquisition of GBT
- Price per share
- $68.50/share
- Stage
- Closed
01 / BuyerPfizer Inc.
02 / TargetGBT
What happened
Pfizer Inc. completed its merger with GBT on Oct. 5, 2022, with GBT surviving as a wholly owned subsidiary of Pfizer Inc.
GBT stockholders were entitled to receive $68.50 per share in cash.
The source
Everything on this page comes from the source below.
01
Source · Source
Pfizer Inc. completes acquisition of GBT
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Closed
The source this page is built from.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly